US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

165.66

-0.9200-0.55%

Post-market: 165.65-0.0104-0.01%17:29 EDT

Volume:7.67M

Turnover:1.27B

Market Cap:43.02B

PE:-11.65

High:167.08

Open:166.50

Low:165.58

Close:166.58

52wk High:176.60

52wk Low:133.73

Shares:259.67M

Float Shares:259.67M

Volume Ratio:0.99

T/O Rate:2.96%

Dividend:2.53

Dividend Rate:1.53%

EPS(TTM):-14.2170

EPS(LYR):-14.2170

ROE:-9.22%

ROA:1.03%

PB:1.25

PE(LYR):-11.65

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocugen (OCGN)

AbbVie Says Atogepant Met Primary, Secondary Endpoints in Phase 3 Menstrual Migraine Study

MT Newswires Live

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday Amid Producer Price Inflation Data Release

MT Newswires Live

AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine

Abbvie - Atogepant Safety Results Consistent with Known Profile; no New Safety Signals

THOMSON REUTERS

Abbvie - Atogepant Meets Primary and All Eight Ranked Secondary Endpoints in Phase 3 Luna Study

THOMSON REUTERS

Abbvie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine

THOMSON REUTERS

Abbvie - Atogepant Shows Significant Improvements Across Multiple Endpoints Versus Placebo

THOMSON REUTERS

Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX

Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses

THOMSON REUTERS

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

Analysts Conflicted on These Healthcare Names: Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS)

Huntington Initiates Sabra Health Care REIT at Outperform With $23 Price Target

MT Newswires Live

Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)

Medtronic (MDT) Receives a Buy from Citi

Edwards Lifesciences (EW) Gets a Buy from Citi

Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cooper Co (COO) and Arcus Biosciences (RCUS)

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live

Epsilon Healthcare Director Alan Beasley Boosts Shareholding via On-Market Purchases

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/XLV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XLV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"Health Care Select Sector SPDR Fund","latestPrice":165.66,"timestamp":1789070400000,"preClose":166.58,"halted":0,"volume":7674368,"hourTrading":{"tag":"盘后","latestPrice":165.6496,"preClose":165.66,"latestTime":"17:29 EDT","volume":52983,"amount":8784136.87263,"timestamp":1789075773211,"change":-0.0104,"changeRate":-0.000063,"amplitude":0.003079},"delay":0,"changeRate":-0.005522871893384655,"floatShares":259665324,"shares":259665324,"eps":-14.217021,"marketStatus":"Post-Mkt","change":-0.92,"latestTime":"09-10 17:31:20 EDT","open":166.5,"high":167.075,"low":165.58,"amount":1274154444.7590399,"amplitude":0.008975,"askPrice":166.12,"askSize":40,"bidPrice":165.5,"bidSize":10,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":166.58,"sharesOutstanding":265215324,"nav":167.125284,"aum":43404997374.42,"dividendRate":0.015284,"bidAskSpread":0.000115,"preHourTrading":{"tag":"盘前","latestPrice":166.51,"preClose":166.58,"latestTime":"09:29 EDT","volume":5759,"amount":962357.92536,"timestamp":1789046999999,"change":-0.07,"changeRate":-0.00042,"amplitude":0.006603},"postHourTrading":{"tag":"盘后","latestPrice":165.6496,"preClose":165.66,"latestTime":"17:29 EDT","volume":52983,"amount":8784136.87263,"timestamp":1789075773211,"change":-0.0104,"changeRate":-0.000063,"amplitude":0.003079},"volumeRatio":0.985938,"impliedVol":0.2388,"impliedVolPercentile":0.9203},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","floatShares":259665324,"roa":"1.03%","roe":"-9.22%","lyrEps":-14.217021,"volumeRatio":0.985938,"shares":259665324,"dividePrice":2.532,"high":167.075,"amplitude":0.008975,"preClose":166.58,"low":165.58,"week52Low":133.725,"pbRate":"1.25","psRate":"65.31","week52High":176.595,"institutionHeld":0.7846,"latestPrice":165.66,"committee":-0.6,"eps":-14.217021,"divideRate":0.015284,"volume":7674368,"delay":0,"ttmEps":-14.217021,"open":166.5,"prevYearClose":154.8,"prevWeekClose":171.45,"prevMonthClose":170.54,"prevQuarterClose":158.66,"fiveDayClose":172.95,"twentyDayClose":168.44,"sixtyDayClose":152.89},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLV\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XLV","amount":0.656252,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2026-03-23","symbol":"XLV","amount":0.59468,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-25","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-25"},{"date":"2025-12-22","symbol":"XLV","amount":0.656822,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XLV","amount":0.624868,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XLV","amount":0.630382,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLV\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.278502,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.305416,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.273839,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.307823,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.304755,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666996625","title":"Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocugen (OCGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666996625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666996625?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:30","pubTimestamp":1789047034,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-axsome-therapeutics-axsm-and-ocugen-ocgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-axsome-therapeutics-axsm-and-ocugen-ocgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4137","LU2324357040.USD","ZYME","BK4139","BK4581","BK4585","BK4563","XBI","LU0029874061.USD","LABU","XLV","PTH","BK4588","OCGN","BK4505","BK4568","AXSM","BK4007","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596073","title":"AbbVie Says Atogepant Met Primary, Secondary Endpoints in Phase 3 Menstrual Migraine Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596073","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596073?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:30","pubTimestamp":1789047005,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) said Thursday that atogepant for the preventive treatment of menstrual migraine in adults met its primary and all eight ranked secondary endpoints in the Phase 3 LUNA study.Atogepant dem","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IXJ","FTXH","IE00BLSP4452.SGD","BK4139","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU0985320562.USD","SG9999001440.SGD","TRUH","LU1934455863.HKD","AGNG","ABBV","LU0965509101.SGD","LU0912757837.SGD","VHT","LU0211328371.USD","IE0004445239.USD","LU1496350171.SGD","PPH","LU0456855351.SGD","PJP","GLAM","RXL","SG9999003800.SGD","SG9999015986.USD","LU0395794307.EUR","LU0029864427.USD","LU0882574055.USD","LU1037948897.HKD","LU1244550577.SGD","LU2129689514.USD","LU0820561818.USD","LU2347655156.SGD","IYH","IE00BVYPNV92.GBP","IE00BLSP4239.USD","LU2125909247.SGD","LU0708994859.HKD","LU2237443622.USD","JDOC","LU1244550221.USD","LU1236620834.HKD","BK4534","IE00BJT1NW94.SGD","LU0820561909.HKD","XLV","LU1061106388.HKD","FHLC","MEDX","LU0511384066.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666489596","title":"Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday Amid Producer Price Inflation Data Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2666489596","media":"MT Newswires Live","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666489596?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:17","pubTimestamp":1789046276,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.6%, and the actively traded Invesco QQQ Trust (QQQ) was 1.5% lower in Thursday's premarket activity amid the release of pr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FDN",".IXIC","FAZ","XLI","XLP","IYK","VDC","XLE","SOXX","SPCX","XLY","BETH","SPY","NAVN","ETH","SLV","IYH","VHT","EETH","GLD","XLV","FAS","YMAX","LEU","STT","RTH.AU","IGM","IYE",".DJI","BITO","QQQ","WSPC","XRT","HGTY","VHT.AU","XLF","EQR","IYJ","SPY.AU","AXGN","VIS","UNG","XLK","XSD","IBB","IYW","USO","RTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596813","title":"AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596813","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596813?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:00","pubTimestamp":1789045214,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced positive topline results from the Phase 3 LUNA study, which evaluated atogepant, a calcitonin gene-related peptide, or CGRP...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvies-atogepant-shows-positive-phase-3-results-in-menstrual-migraine-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvies-atogepant-shows-positive-phase-3-results-in-menstrual-migraine-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1236620834.HKD","FTXH","LU0965508806.USD","LU1057294990.SGD","LU2237443465.HKD","IE00BN8TJ469.HKD","IE00BSNM7G36.USD","IE0000B7K699.USD","AGNG","LU0128525929.USD","MEDX","LU0823416689.USD","LU0859254822.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU0170899867.USD","LU2357627491.SGD","LU0795875086.SGD","LU0949170772.SGD","LU1670628061.USD","PJP","PPH","LU0289739699.SGD","LU2237443382.USD","IE000MB6IJN5.SGD","VHT","ABBV","BK4550","BK4139","BK4588","IYH","LU1989772923.USD","IE00B2B36J28.USD","JDOC","LU0114720955.EUR","LU1934455863.HKD","LU0661504455.SGD","LU0553294199.USD","GLAM","BK4581","LU0203345920.USD","LU0726765562.USD","BK4534","IXJ","RXL","LU0256863811.USD","FHLC","IE00BBT3K403.USD","TRUH","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666954045","title":"Abbvie - Atogepant Safety Results Consistent with Known Profile; no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2666954045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666954045?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:55","pubTimestamp":1789044900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8RPXBH:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1244550494.USD","LU0158827948.USD","LU1989772923.USD","LU1732800096.USD","LU0289739343.SGD","LU0949170772.SGD","TRUH","LU2125909593.SGD","IE000BZT7R73.USD","PJP","SG9999001440.SGD","ABBV","RXL","LU0417517546.SGD","LU1496350171.SGD","LU1267930573.SGD","BK4559","PPH","IYH","SG9999015978.USD","LU0820561909.HKD","LU0545039389.USD","AGNG","MEDX","VHT","LU0456855351.SGD","LU1291159041.SGD","LU1929549753.HKD","LU0289961442.SGD","IE00BN8TJ469.HKD","IE00BDGV0183.EUR","LU1934455194.USD","LU2433249047.HKD","LU2133065610.SGD","IE00BGHQF631.EUR","LU2125909247.SGD","SG9999015986.USD","FHLC","LU0726765562.USD","FTXH","JDOC","IE00BLSP4239.USD","XLV","IXJ","LU0689626769.HKD","GLAM","LU0965508806.USD","LU0170899867.USD","BK4581","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666595402","title":"Abbvie - Atogepant Meets Primary and All Eight Ranked Secondary Endpoints in Phase 3 Luna Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666595402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666595402?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:55","pubTimestamp":1789044900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8RPXBH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGNG","LU0965509010.AUD","LU0122379950.USD","LU1670628061.USD","LU1551013425.SGD","LU1934455194.USD","LU1093756168.USD","IE0004445239.USD","LU0553294199.USD","LU1244550577.SGD","LU0432979614.USD","LU2347655156.SGD","LU0820561909.HKD","IE000BZT7R73.USD","XLV","LU1718418525.SGD","LU2089984988.USD","LU0795875169.SGD","RXL","LU1496350502.SGD","LU1934455863.HKD","IE00B3PB1722.GBP","LU2237443549.SGD","FHLC","LU0472753341.HKD","LU0395794307.EUR","LU2089283258.USD","LU0158827948.USD","LU1244550221.USD","PPH","PJP","IXJ","BK4559","LU0203347892.USD","LU1732800096.USD","IE00B2B36J28.USD","GLAM","TRUH","JDOC","ABBV","LU1037948897.HKD","MEDX","IE00B42XCP33.USD","IYH","LU0417517546.SGD","LU1983299246.USD","FTXH","IE00BFTCPJ56.SGD","VHT","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666595401","title":"Abbvie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine","url":"https://stock-news.laohu8.com/highlight/detail?id=2666595401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666595401?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:55","pubTimestamp":1789044900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8RPXBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237443382.USD","LU2089984988.USD","LU2237443465.HKD","LU0203345920.USD","LU0553294199.USD","PJP","IE00B2B36J28.USD","LU0949170772.SGD","LU0661504455.SGD","LU1934455863.HKD","LU1236620834.HKD","LU0170899867.USD","LU1057294990.SGD","BK4534","JDOC","IYH","ABBV","BK4588","LU0256863811.USD","PPH","IE0000B7K699.USD","BK4581","BK4550","LU0114720955.EUR","IE00BN8TJ469.HKD","RXL","IE00BFTCPJ56.SGD","LU0128525929.USD","BK4139","LU0726765562.USD","LU0965508806.USD","FTXH","IE000MB6IJN5.SGD","VHT","IE00BSNM7G36.USD","MEDX","LU0289739699.SGD","IXJ","LU2357627491.SGD","IE00BBT3K403.USD","AGNG","GLAM","LU0795875086.SGD","LU1989772923.USD","LU0859254822.USD","LU0823416689.USD","TRUH","LU1670628061.USD","FHLC","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666059540","title":"Abbvie - Atogepant Shows Significant Improvements Across Multiple Endpoints Versus Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2666059540","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666059540?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:55","pubTimestamp":1789044900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8RPXBH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE000SO60NU8.SGD","XLV","AGNG","LU1839511570.USD","PJP","LU1496350502.SGD","IE00B3PB1722.GBP","LU1732800096.USD","LU0545039389.USD","LU2089284900.SGD","LU0289739343.SGD","IE00B19Z3B42.SGD","JDOC","LU2133065610.SGD","IE0002141913.USD","BK4585","IXJ","LU0868494708.USD","VHT","IE0004445239.USD","IYH","TRUH","ABBV","LU0820561818.USD","BK4534","FHLC","LU1162221912.USD","LU1923622614.USD","IE0009355771.USD","IE000BZT7R73.USD","LU1732799900.SGD","LU2237443622.USD","PPH","IE0000B7K699.USD","LU0417517546.SGD","LU0472753341.HKD","LU1934455194.USD","LU2468319806.SGD","IE00BVYPNW00.USD","GLAM","LU1983299246.USD","LU0128525929.USD","LU1989771016.USD","RXL","MEDX","SG9999001440.SGD","FTXH","LU2125909247.SGD","LU2129689431.USD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666598426","title":"Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX","url":"https://stock-news.laohu8.com/highlight/detail?id=2666598426","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666598426?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:50","pubTimestamp":1789041051,"startTime":"0","endTime":"0","summary":"Johnson & Johnson has received CE Marking for ACUVUE OASYS MAX 2-Week, a new reusable contact lens featuring proprietary MAX technologies designed ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-receives-ce-marking-for-acuvue-oasys-max-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-receives-ce-marking-for-acuvue-oasys-max-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","SGXZ57979304.SGD","BK4078","IE00B7SZLL34.SGD","LU2750360641.GBP","LU0345770308.USD","TRUH","IE00B3PB1722.GBP","IE000M9KFDE8.USD","LU1228905037.USD","MAX","IE00B2B36J28.USD","SG9999002232.USD","IE00BVYPNW00.USD","MEDX","IE0000B7K699.USD","LU1929549753.HKD","LU0345769631.USD","LU2471134952.CNY","LU0203347892.USD","LU0689626769.HKD","IE00BDGV0183.EUR","GPRO","PJP","IE00BLSP4452.SGD","JDOC","IE00BSNM7G36.USD","BK4533","BK4559","LU0320765646.SGD","LU0787776722.HKD","VHT","LU1894683264.USD","RXL","JNJ","LU0234570918.USD","LU1066053197.SGD","IHE","FHLC","BK4581","BMED","XLV","IYH","LU1032955483.USD","LU0943347566.SGD","LU1280957306.USD","IE000MB6IJN5.SGD","FTXH","IXJ","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666598631","title":"Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2666598631","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666598631?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:45","pubTimestamp":1789040700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA26VGSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2592432038.USD","LU1032466523.USD","LU0320765646.SGD","TRUH","LU0345770308.USD","LU0432979614.USD","LU2602419157.SGD","IE00BJT1NW94.SGD","LU1261432733.SGD","LU2129689605.HKD","LU1032955483.USD","LU1043141396.HKD","PJP","BK4504","IE000WAW04H5.SGD","BK4533","RXL","LU2089984988.USD","JNJ","IE00B4R5TH58.HKD","IE00BVYPNW00.USD","BK4559","IYH","IE00BBT3K403.USD","LU0058720904.USD","LU0466842654.USD","LU1935042991.SGD","BMED","MEDX","VHT","LU1291159041.SGD","LU1057294990.SGD","BK4550","LU1506573853.SGD","FHLC","LU2487616109.SGD","GDOC","SGXZ57979304.SGD","FTXH","IHE","IE00BFXG1179.USD","IE00BLSP4239.USD","LU1074936037.SGD","LU1280957306.USD","XLV","IXJ","LU1894683264.USD","LU2750360641.GBP","LU2023250330.USD","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666959862","title":"Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York","url":"https://stock-news.laohu8.com/highlight/detail?id=2666959862","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666959862?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:30","pubTimestamp":1789039800,"startTime":"0","endTime":"0","summary":"CEO Michael Halstead to participate in a fireside chat on Wednesday, September 16, 2026 at 8:30 a.m. EDT.NEW YORK and TORONTO, Sept.  10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA:","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359394/0/en/helus-pharma-to-participate-at-the-morgan-stanley-24th-annual-global-healthcare-conference-in-new-york.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","KBWB","LU0053666078.USD","BK4504","IAI","LU0390134368.USD","LU2028103732.USD","LU1989772923.USD","XLV","LU0128526141.USD","LU1162221912.USD","LU0158827948.USD","LU1363072403.SGD","LU1244550494.USD","LU1720051017.SGD","LU2271345857.HKD","LABU","LU2357305700.SGD","LU0971096721.USD","LU1791710400.SGD","LU1732800096.USD","BK4127","XBI","LU0528227936.USD","LU1064131342.USD","LU0912757837.SGD","LU2133065610.SGD","LU0557290698.USD","LU0882574139.USD","LU0267386448.USD","LU2347655156.SGD","LU1668664300.SGD","LU1988902786.USD","HCSG","LU2111349929.HKD","LU2023251221.USD","LU1989772840.SGD","LU0098860793.USD","BK4534","LU0106261372.USD","LU0225283273.USD","LU1548497426.USD","LU0006306889.USD","LU1720051108.HKD","LU0158827781.USD","LU2089283258.USD","BK4137","LU0314104364.USD","LU0795875169.SGD","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666560420","title":"Analysts Conflicted on These Healthcare Names: Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560420","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560420?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:10","pubTimestamp":1789038608,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS). Xeris Pharmace...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-xeris-pharmaceuticals-xers-and-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-xeris-pharmaceuticals-xers-and-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0128526141.USD","LU0029874061.USD","XLV","PHVS","XERS","BK4585","BK4581","HCSG","XBI","LABU","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666601560","title":"Huntington Initiates Sabra Health Care REIT at Outperform With $23 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2666601560","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666601560?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:09","pubTimestamp":1789038599,"startTime":"0","endTime":"0","summary":"Sabra Health Care REIT (SBRA) has an average rating of overweight and mean price target of $22.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RNTY","SBRA","CFA.SI","YLDW","IQRA","DFRA","PSCF","BPRE","8C8U.SI","RJMG","IVRA","XLV","MDIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666356779","title":"Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666356779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666356779?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:50","pubTimestamp":1789037412,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunic (IMUX), Celldex (CLDX) and Cooper Co (COO) w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immunic-imux-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immunic-imux-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","CLDX","LU2272731782.SGD","HCSG","IMUX","BK4585","COO","LU1992135399.USD","XLV","LABU","BK4198","LU0029874061.USD","LU2272731600.USD","BK4139","GB00BDT5M118.USD","LU1992135472.HKD","XBI","LU2211815571.USD","LU0128526141.USD","BK4137","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666562198","title":"Medtronic (MDT) Receives a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666562198","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666562198?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:16","pubTimestamp":1789035398,"startTime":"0","endTime":"0","summary":"Citi analyst Joanne Wuensch maintained a Buy rating on Medtronic today and set a price target of $110.00. Wuensch covers the Healthcare sector, foc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/medtronic-mdt-receives-a-buy-from-citi-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/medtronic-mdt-receives-a-buy-from-citi-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1116320737.USD","IE00B42XCP33.USD","LU1989764748.USD","LU1989771016.USD","BK4581","LU2271345857.HKD","IE00B3PB1722.GBP","LU1116320901.HKD","LU0265550359.USD","LU2089283258.USD","LU1061106388.HKD","LU2028103732.USD","LU1023059063.AUD","LU0496365809.HKD","IE00BDGV0183.EUR","XBI","IE00BQXX3F31.USD","BK4082","LU1983299246.USD","LU1571399168.USD","BK4566","LU0976567544.SGD","IE00B3T34201.USD","LU0158827948.USD","IE00BVYPNW00.USD","LU0211326839.USD","MDT","IE000M9KFDE8.USD","IE00BFXG1179.USD","BK4533","XLV","LABU","LU0211331839.USD","LU2468319806.SGD","LU0432979614.USD","BK4585","LU0314106906.USD","LU1057294990.SGD","LU2112291526.USD","LU1244550221.USD","IE00BGHQF631.EUR","LU0211326755.USD","LU1506573853.SGD","LU1291159041.SGD","LU0158827781.USD","LU0106261372.USD","LU0006306889.USD","LU2089984988.USD","BK4588","LU1989764664.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666968562","title":"Edwards Lifesciences (EW) Gets a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666968562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666968562?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:16","pubTimestamp":1789035394,"startTime":"0","endTime":"0","summary":"Citi analyst Joanne Wuensch maintained a Buy rating on Edwards Lifesciences today and set a price target of $110.00. Wuensch covers the Healthcare ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/edwards-lifesciences-ew-gets-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/edwards-lifesciences-ew-gets-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BMED","LU0345774391.USD","IE00BYQQ9H92.USD","BK4585","IE00BN0W2T93.GBP","SGXZ57979304.SGD","IE00BN0W2W23.USD","XLV","SG9999001176.SGD","LU0823416689.USD","IHI","SG9999013999.USD","BK4082","LABU","LU0058720904.USD","BK4504","IE00BN0W2V16.EUR","AGNG","XBI","SG9999001176.USD","EW","IE00BFXG0V08.USD","LU0345774631.USD","BK4567","BK4588","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666199562","title":"Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cooper Co (COO) and Arcus Biosciences (RCUS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666199562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666199562?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:10","pubTimestamp":1789035029,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Brainsway (BWAY), Cooper Co (COO) and Arcus Biosci...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-brainsway-bway-cooper-co-coo-and-arcus-biosciences-rcus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-brainsway-bway-cooper-co-coo-and-arcus-biosciences-rcus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0128526141.USD","LU2272731782.SGD","XBI","LU2272731600.USD","LABU","BK4139","COO","LU2211815571.USD","BK4198","LU1992135399.USD","BK4581","HCSG","RCUS","BWAY","BK4588","LU1992135472.HKD","GB00BDT5M118.USD","XLV","LU0029874061.USD","BK4082","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666856274","title":"Man Group PLC : Form 8.3 - Spire Healthcare Group Plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2666856274","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666856274?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:02","pubTimestamp":1789034520,"startTime":"0","endTime":"0","summary":"FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359280/0/en/man-group-plc-form-8-3-spire-healthcare-group-plc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","XBI","BK4588","LU0029874061.USD","LU0128526141.USD","LABU","BK4581","XLV","BK4585","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666561456","title":"HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666561456","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666561456?lang=en_us&edition=fundamental","pubTime":"2026-09-10 17:34","pubTimestamp":1789032857,"startTime":"0","endTime":"0","summary":"Eli Lilly and Company (LLY) has an average rating of overweight and mean price target of $1,352.49, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0354030438.USD","RXL","LU2417539215.USD","LU2756315664.SGD","LU2106854487.HKD","BK4599","LU2471134796.USD","LU1280957306.USD","LU1366192091.USD","IYH","SG9999014880.SGD","LU2461242641.AUD","IE00BKPKM429.USD","LU2360106947.USD","LU0432979614.USD","LU0471298777.SGD","IE00BFSS8Q28.SGD","LU0266013472.USD","LLYX","LU0882574055.USD","LU2023251221.USD","LU0689472784.USD","TMED","LU0466842654.USD","LU0820561909.HKD","IE0001KFT4U8.USD","PPH","LU0672654240.SGD","LU1629891620.HKD","SG9999001176.USD","LU0256863902.USD","IE00BN29S564.USD","IE00BJLML261.HKD","LU1868837300.USD","LU2237443465.HKD","BK4585","LU2089984988.USD","LU0320765992.SGD","LU2237443382.USD","LU2108987350.USD","LU1323610961.USD","LU0316494557.USD","LU2023250504.SGD","LU0823416689.USD","SG9999013999.USD","PJP","IE00BWXC8680.SGD","VHT","IE00B1XK9C88.USD","LU2462157665.USD","LU0320765059.SGD","LU2361045086.USD","BK4588","IHE","LU2750360641.GBP","LU0882574139.USD","LU0385154629.USD","LU2112291526.USD","IE00BKDWB100.SGD","SGXZ57979304.SGD","LU2602419157.SGD","LU1868836757.USD","LU2491049909.HKD","LU2237438978.USD","LU1868837136.USD","LU0238689110.USD","LU1691799644.USD","LU1720051108.HKD","LU2896262040.SGD","LLII","LU0109391861.USD","LU1983299246.USD","SG9999018865.SGD","LU0323591593.USD","CURE","SGXZ51526630.SGD","LU0820562030.AUD","LU2756315318.SGD","LU1814569148.SGD","IE00B7KXQ091.USD","IE00BFSS7M15.SGD","LU2211815571.USD","LU1974910355.USD","LU2471134879.HKD","LU0203201768.USD","IXJ","LU2236285917.USD","LU0823434740.USD","LU2552382215.SGD","LU2471134952.CNY","LU0417517546.SGD","LU1093756168.USD","THNR","GDOC","LU2237443895.HKD","LU2750360997.AUD","LU2361044949.HKD","BK4581","LU0061475181.USD","LU2552382058.USD","SG9999015945.SGD","LU1623119135.USD","LU2089284900.SGD","LU0106261372.USD","SG9999014898.SGD","LU0006306889.USD","LU0174119429.USD","IE0004445239.USD","ELIS","IE00B4JS1V06.HKD","LU0889565916.HKD","LU2063271972.USD","ELIL","LU2265009873.SGD","IE00B2B36J28.USD","IE00BJJMRY28.SGD","LU0198837287.USD","LU1023059063.AUD","LU1712237335.SGD","LU1989771016.USD","BK4534","LU0079474960.USD","LU0353189763.USD","LU2111349929.HKD","LU2168564149.EUR","LU2168564222.USD","LU0823434583.USD","LU2168564065.EUR","LU2357305700.SGD","LU2746668461.USD","SGXZ99366536.SGD","LU2168564495.EUR","SG9999015986.USD","LU0456855351.SGD","LU0234572021.USD","BK4533","LU0683600562.USD","LU1127390331.HKD","LU1979441026.SGD","LU2456880835.USD","IE00BK4W5L77.USD","LU2468319806.SGD","LU0097036916.USD","AGNG","LU0640476718.USD","LU1232071149.USD","LU2237443549.SGD","IE00B775H168.HKD","LU0158827781.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0964807845.USD","SGXZ81514606.USD","SGXZ31699556.SGD","SG9999001176.SGD","LU1267930730.SGD","IE00BJJMRZ35.SGD","LU1291159041.SGD","SG9999014914.USD","LU1868836914.USD","IE0005OL40V9.USD","LU1551013425.SGD","LU2087625088.SGD","LU2324357040.USD","LU1069344957.HKD","LU2271345857.HKD","SG9999015978.USD","LU1804176565.USD","LU2491050154.USD","LU0109394709.USD","SG9999015952.SGD","HRTS","FTXH","IE0002141913.USD","LU0820561818.USD","LU2237443978.SGD","IE00B4R5TH58.HKD","FHLC","LU0210536198.USD","LU1093756325.SGD","LU1868836591.USD","LU2168563687.JPY","MHIP","LU0787776722.HKD","LU0122379950.USD","LU2237443622.USD","IE0004445015.USD","LU0094547139.USD","IE00BJT1NW94.SGD","LU0786609619.USD","LU2746668974.SGD","BK4007","SG9999018857.SGD","TRUH","LU0345770308.USD","LU0256863811.USD","LU1988902786.USD","LU0133085943.USD","LU2264538146.SGD","IE00BJJMRX11.SGD","JDOC","LU2028103732.USD","LU1720051017.SGD","LU1145028129.USD","LU0158827948.USD","GB00BDT5M118.USD","LU0114720955.EUR","LU1551013342.USD","LU1917777945.USD","LU2089283258.USD","LU2471134523.USD","LU1061106388.HKD","OZEM","SG9999014906.USD","CANC","MEDX","LU1057294990.SGD","LU0471298694.HKD","LU1548497426.USD","LU0353189680.USD","IE00BK4W5M84.HKD","IE0009355771.USD","WDNA","SG9999017495.SGD","LLY","LU0225283273.USD","LU0203202063.USD","LU0943347566.SGD","LU2491050071.SGD","LU0345770993.USD","LU0289739699.SGD","XLV","LLYZ","LU2023250330.USD","LU2213496289.HKD","ILDR","LU0708995401.HKD","LU2552382132.HKD","BK4516","LU0354030511.USD","LU1035775433.USD","IE00B1BXHZ80.USD","MEDI","LU2361044865.SGD","LU0096364046.USD","LU2462591350.SGD","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666715561","title":"Epsilon Healthcare Director Alan Beasley Boosts Shareholding via On-Market Purchases","url":"https://stock-news.laohu8.com/highlight/detail?id=2666715561","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666715561?lang=en_us&edition=fundamental","pubTime":"2026-09-10 17:27","pubTimestamp":1789032433,"startTime":"0","endTime":"0","summary":"An update from Epsilon Healthcare Limited ( ($AU:EPN) ) is now available. Epsilon Healthcare Limited has disclosed a change in the holdings of dire...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epsilon-healthcare-director-alan-beasley-boosts-shareholding-via-on-market-purchases?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epsilon-healthcare-director-alan-beasley-boosts-shareholding-via-on-market-purchases?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XLV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":26,"pageCount":2,"totalSize":514,"code":"91000000","status":"200"}]}}